Full Press Release Details
This amended and restated business acquisition report (the "Amended and Restated BAR") amends and restates and supersedes the business acquisition report of Canopy Growth Corporation (the "Company") dated September 18, 2018 (the "Original BAR").
This Amended and Restated BAR replaces (i) the unaudited pro-forma condensed interim consolidated statement of financial position of the Company as at June 30, 2018; (ii) the unaudited pro-forma condensed consolidated statement of operations of the Company and pro-forma earnings per share for the year ended March 31, 2018; and (iii) the unaudited pro-forma condensed interim consolidated statement of operations of the Company and pro-forma earnings per share for the three months ended June 30, 2018 (the "Pro Forma Financial Statements"). In the Original BAR, the Company accounted for its 67% interest in BC Tweed Joint Venture Inc. ("BC Tweed") as a joint operation, based on the conclusion that BC Tweed was subject to joint control. During the second quarter of fiscal 2019, the Company revised this conclusion and concluded that BC Tweed was unilaterally controlled by the Company and accordingly the Pro Forma Financial Statements have been replaced in the Amended and Restated BAR to address the change in accounting treatment.
This explanatory note does not form a part of, and is not incorporated by reference in, the Amended and Restated BAR.
AMENDED AND RESTATED BUSINESS ACQUISITION REPORT
| Item 1. | Identity of Company |
| 1.1. | Name and Address of Company Canopy Growth Corporation (the " Company ") 1 Hershey Drive Smiths Falls, Ontario K7A 0A8 |
| 1.2. | Executive Officer The following executive officer of the Company is knowledgeable about the Acquisition (as defined below) and this report: Mr. Tim Saunders Executive Vice President & Chief Financial Officer Telephone: (613) 706-2185 ext. 150 |
| Item 2. | Details of Acquisition |
| 2.1. | Nature of Business Acquired All amounts in this business acquisition report are stated in Canadian dollars unless stated otherwise. On May 14, 2018, the Company announced that it entered into a non-binding agreement to purchase the 33% interest in BC Tweed Joint Venture Inc. (" BC Tweed ") held by 1135012 B.C. Ltd. The Company held the remaining 67% interest in BC Tweed. On July 5, 2018, the Company announced that it had completed the acquisition (the " Acquisition ") of the 33% interest in BC Tweed pursuant to a share purchase agreement dated July 4, 2018, as amended as of July 5, 2018 (the " Purchase Agreement "). BC Tweed was incorporated by the Company on September 12, 2017. On October 10, 2017, the Company entered into a definitive joint venture agreement with 1135024 B.C. Ltd. to develop a greenhouse growing facility in Aldergrove, British Columbia, Canada with an exclusive option to develop a further 1.7 million square feet of existing greenhouse infrastructure at a second location in Delta, British Columbia, Canada. On December 1, 2017, BC Tweed entered into an agreement to lease the second greenhouse growing facility in Delta, British Columbia, Canada. The Aldergrove site includes the first and second stage licensing of 840,000 square feet of growing space, allowing vegetative growth so that the mature plants can be spread into the full 1.3 million square feet for flowering and harvesting. The Delta site includes the initial licensing of 900,000 square feet of growing space, allowing vegetative growth so that the mature plants can be spread into the full 1.7 million square feet for flowering and harvesting. |
| 2.2. | Date of Acquisition July 5, 2018. |
| 2.3. | Consideration Pursuant to the Purchase Agreement, the Company completed the Acquisition for initial cash consideration of $1 million and 12,619,148 common shares of the Company (the " Consideration Shares ") having a value on the closing date of approximately $440,596,103. 8,202,446 Consideration Shares are subject to the terms of an escrow agreement, all of which will be released by no later than July 5, 2021. The Company also acquired a call option over certain entities that hold greenhouses and related property. The Company issued 674,821 common shares of the Company in exchange for the option, having a value on the closing date of approximately $26,790,394. |
| 2.4. | Effect on Financial Position The Company does not currently have any plans or proposals for material changes in the business acquired pursuant to the Acquisition which may have a significant impact on the financial performance and financial position of the Company, including any proposal to sell, lease or exchange all or a substantial part of the business acquired pursuant to the Acquisition or to make any material changes to the Company's business. |
| 2.5. | Prior Valuations No valuation opinion was required by securities legislation or a Canadian exchange or market within the last 12 months to support the consideration paid by the Company pursuant to the Acquisition. |
| 2.6. | Parties to Transaction The Acquisition was not with an informed person (as that term is defined in section 1.1 of National Instrument 51-102 - Continuous Disclosure Obligations ) , associate or affiliate of the Company. |
| 2.7. | Date of Report December 20, 2018 |
| Item 3. | Financial Statements and Other Information |
| The Acquisition constitutes a "step-by-step" acquisition. Accordingly, in reliance on section 8.11 of National Instrument 51-102, the Company is exempt from providing audited financial statements of BC Tweed, as BC Tweed has been consolidated since October 10, 2017 in the Company's most recent annual financial statements for the year ended March 31, 2018. The following pro-forma documents of the Company are attached as Schedule "A" to this business acquisition report: (a)The unaudited pro-forma condensed interim consolidated statement of financial position of the Company as at June 30, 2018; (b)The unaudited pro-forma condensed consolidated statement of operations of the Company and pro-forma earnings per share for the year ended March 31, 2018; and (c)The unaudited pro-forma condensed interim consolidated statement of operations of the Company and pro-forma earnings per share for the three months ended June 30, 2018. |
Cautionary Note Regarding Forward Looking Statements
This business acquisition report contains "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" " within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, BC Tweed or the Company's subsidiaries or affiliates to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this business acquisition report. Examples of such statements include the satisfaction of certain conditions and the release of the Consideration Shares from escrow. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks associated with changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; diversion of management
time on the integration of the business; and such risks contained in the Company's annual information form dated June 27, 2018 and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this business acquisition report are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements included in this business acquisition report are made as of the date of this business acquisition report and the Company does not undertake an obligation to publicly update such forward-looking statements or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws.
PRO-FORMA FINANCIAL STATEMENTS
| CANOPY GROWTH CORPORATION | ||||||||||||||||
| PRO FORMA CONDENSED INTERIM CONSOLIDATED STATEMENT OF FINANCIAL POSITION | ||||||||||||||||
| AS AT JUNE 30, 2018 | ||||||||||||||||
| UNAUDITED | Canopy | Pro Forma | Pro Forma | |||||||||||||
| (Expressed in CDN $000's) | Growth | Adjustments | Notes | Consolidated | ||||||||||||
| Assets | ||||||||||||||||
| Current assets | ||||||||||||||||
| Cash and cash equivalents | $ | 657,896 | $ | 657,896 | ||||||||||||
| Amounts receivable | 27,746 | 27,746 | ||||||||||||||
| Biological assets | 52,811 | 52,811 | ||||||||||||||
| Inventory | 118,204 | 118,204 | ||||||||||||||
| Prepaid expenses and other assets | 36,137 | (1,000 | ) | 3 | 35,137 | |||||||||||
| 892,794 | (1,000 | ) | 891,794 | |||||||||||||
| Property, plant and equipment | 479,898 | 479,898 | ||||||||||||||
| Other long-term assets | 26,973 | 26,973 | ||||||||||||||
| Investments in associates and joint ventures | 93,269 | 93,269 | ||||||||||||||
| Other financial assets | 177,282 | 177,282 | ||||||||||||||
| Intangible assets | 101,723 | 101,723 | ||||||||||||||
| Goodwill | 340,374 | 340,374 | ||||||||||||||
| $ | 2,112,313 | $ | (1,000 | ) | $ | 2,111,313 | ||||||||||
| Liabilities | ||||||||||||||||
| Current liabilities | ||||||||||||||||
| Accounts payable and accrued liabilities | $ | 127,248 | $ | 127,248 | ||||||||||||
| Deferred revenue | 767 | 767 | ||||||||||||||
| Current portion of long-term debt | 2,539 | 2,539 | ||||||||||||||
| 130,554 | - | 130,554 | ||||||||||||||
| Long-term debt | 617,749 | 617,749 | ||||||||||||||
| Deferred tax liability | 30,815 | 30,815 | ||||||||||||||
| Long-term financial liabilities | 108,732 | (72,600 | ) | 3) | 63,132 | |||||||||||
| 27,000 | 3) | |||||||||||||||
| 887,850 | (45,600 | ) | 842,250 | |||||||||||||
| Shareholders' equity | ||||||||||||||||
| Share capital | 1,124,485 | 202,133 | 3) | 1,326,618 | ||||||||||||
| Other reserves | 145,564 | 265,253 | 3) | (11,015 | ) | |||||||||||
| (422,786 | ) | 3) | ||||||||||||||
| 954 | 4b) | |||||||||||||||
| Accumulated other comprehensive income | 39,280 | 39,280 | ||||||||||||||
| Deficit | (171,926 | ) | (954 | ) | 4b) | (172,880 | ) | |||||||||
| Equity attributable to Canopy Growth Corporation | 1,137,403 | 44,600 | 1,182,003 | |||||||||||||
| Non-controlling interests | 87,060 | 87,060 | ||||||||||||||
| Total equity | 1,224,463 | 44,600 | 1,269,063 | |||||||||||||
| $ | 2,112,313 | $ | (1,000 | ) | $ | 2,111,313 |
| CANOPY GROWTH CORPORATION | ||||||||||||||
| PRO FORMA CONDENSED INTERIM CONSOLIDATED STATEMENT OF OPERATIONS | ||||||||||||||
| FOR THE THREE MONTHS ENDED JUNE 30, 2018 | ||||||||||||||
| UNAUDITED | Canopy | Pro Forma | Pro Forma | |||||||||||
| (Expressed in CDN $000's except share amounts) | Growth | Adjustments | Notes | Consolidated | ||||||||||
| Revenue | $ | 25,916 | $ | 25,916 | ||||||||||
| Inventory production costs expensed to cost of sales | 14,832 | 14,832 | ||||||||||||
| Gross margin before the undernoted | 11,084 | 11,084 | ||||||||||||
| Fair value changes in biological assets included in inventory sold and other inventory charges | 26,388 | 26,388 | ||||||||||||
| Unrealized gain on changes in fair value of biological assets | (57,289 | ) | (57,289 | ) | ||||||||||
| Gross margin | 41,985 | 41,985 | ||||||||||||
| Sales and marketing | 17,266 | 17,266 | ||||||||||||
| Research and development | 756 | 756 | ||||||||||||
| General and administration | 19,588 | 19,588 | ||||||||||||
| Acquisition-related costs | 1,884 | 1,884 | ||||||||||||
| Share-based compensation expense | 23,072 | 23,072 | ||||||||||||
| Share-based compensation expense related to acquisition milestones | 7,095 | 7,095 | ||||||||||||
| Depreciation and amortization | 3,030 | 3,030 | ||||||||||||
| Operating expenses | 72,691 | 72,691 | ||||||||||||
| Loss from operations | (30,706 | ) | (30,706 | ) | ||||||||||
| Share of loss on equity investments | (2,569 | ) | (2,569 | ) | ||||||||||
| Other expense, net | (60,426 | ) | 16,300 | 4a) | (44,126 | ) | ||||||||
| Total other expense, net | (62,995 | ) | 16,300 | (46,695 | ) | |||||||||
| Loss before income taxes | (93,701 | ) | 16,300 | (77,401 | ) | |||||||||
| Income tax (expense) recovery | 2,723 | 2,723 | ||||||||||||
| Net loss | $ | (90,978 | ) | $ | 16,300 | $ | (74,678 | ) | ||||||
| Net loss attributable to: | ||||||||||||||
| Canopy Growth Corporation | $ | (80,277 | ) | $ | 16,300 | $ | (63,977 | ) | ||||||
| Non-controlling interests | (10,701 | ) | (10,701 | ) | ||||||||||
| $ | (90,978 | ) | $ | 16,300 | $ | (74,678 | ) | |||||||
| Earnings per share, basic and diluted | ||||||||||||||
| Net loss per share: | $ | (0.40 | ) | $ | (0.30 | ) | ||||||||
| Weighted average number of outstanding common shares: | 200,160,740 | 13,293,969 | 213,454,709 |
| CANOPY GROWTH CORPORATION | ||||||||||||||
| PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS | ||||||||||||||
| FOR THE YEAR ENDED MARCH 31, 2018 | ||||||||||||||
| UNAUDITED | Canopy | Pro Forma | Pro Forma | |||||||||||
| (Expressed in CDN $000's except share amounts) | Growth | Adjustments | Notes | Consolidated | ||||||||||
| Revenue | $ | 77,948 | $ | 77,948 | ||||||||||
| Inventory production costs expensed to cost of sales | 37,790 | 37,790 | ||||||||||||
| Gross margin before the undernoted | 40,158 | 40,158 | ||||||||||||
| Fair value changes in biological assets included in inventory sold and other inventory charges | 66,268 | 66,268 | ||||||||||||
| Unrealized gain on changes in fair value of biological assets | (100,302 | ) | (100,302 | ) | ||||||||||
| Gross margin | 74,192 | 74,192 | ||||||||||||
| Sales and marketing | 38,203 | 38,203 | ||||||||||||
| Research and development | 1,453 | 1,453 | ||||||||||||
| General and administration | 43,819 | 43,819 | ||||||||||||
| Acquisition-related costs | 3,406 | 3,406 | ||||||||||||
| Share-based compensation expense | 29,631 | 29,631 | ||||||||||||
| Share-based compensation expense related to acquisition milestones | 19,475 | 954 | 4b) | 20,429 | ||||||||||
| Depreciation and amortization | 20,486 | 20,486 | ||||||||||||
| Operating expenses | 156,473 | 954 | 157,427 | |||||||||||
| Loss from operations | (82,281 | ) | (954 | ) | (83,235 | ) | ||||||||
| Share of loss on equity investments | (1,473 | ) | (1,473 | ) | ||||||||||
| Other income (expense), net | 31,213 | 19,900 | 4b) | 56,108 | ||||||||||
| 4,995 | 4c) | |||||||||||||
| Total other income, net | 29,740 | 24,895 | 54,635 | |||||||||||
| Income (loss) before income taxes | (52,541 | ) | 23,941 | (28,600 | ) | |||||||||
| Income tax (expense) recovery | (1,593 | ) | (1,593 | ) | ||||||||||
| Net income (loss) | $ | (54,134 | ) | $ | 23,941 | $ | (30,193 | ) | ||||||
| Net income (loss) attributable to: | ||||||||||||||
| Canopy Growth Corporation | $ | (70,353 | ) | $ | 23,941 | $ | (46,412 | ) | ||||||
| Non-controlling interests | 16,219 | 16,219 | ||||||||||||
| $ | (54,134 | ) | $ | 23,941 | $ | (30,193 | ) | |||||||
| Earnings per share | ||||||||||||||
| Net income (loss) per share, basic: | $ | (0.40 | ) | $ | (0.24 | ) | ||||||||
| Weighted average number of outstanding common shares, basic: | 177,301,767 | 13,293,969 | 190,595,736 |
Canopy Growth Corporation
Notes to Unaudited Pro Forma Condensed Consolidated Financial Statements
(amounts in Canadian thousands of dollars unless noted otherwise, except for per share amounts)
1. BASIS OF PRESENTATION
The unaudited pro forma condensed interim consolidated statement of financial position as at June 30, 2018, the unaudited pro forma condensed interim consolidated statement of operations for the three months ended June 30, 2018 and the unaudited pro forma condensed consolidated statement of operations for the year ended March 31, 2018 of Canopy Growth Corporation ("Canopy") were prepared for illustrative purposes only in compliance with National Instrument 51-102 - Continuous Disclosure Obligations.
The unaudited pro forma condensed consolidated statement of financial position and the unaudited pro forma condensed consolidated statements of operations of Canopy are comprised of information derived from:
The unaudited pro forma condensed consolidated financial statements do not include all of the disclosures required by International Financial Reporting Standards ("IFRS") and should be read in conjunction with Canopy's unaudited condensed interim consolidated financial statements for the three months ended June 30, 2018 and the audited consolidated financial statements of Canopy for the year ended March 31, 2018.
The unaudited pro forma consolidated financial information gives effect to the acquisition of the minority shareholder's ("Partner's") interest in BC Tweed as if it had occurred as at June 30, 2018, for the purposes of the unaudited pro forma condensed interim consolidated statement of financial position and as at April 1, 2017 for the purposes of the unaudited pro forma consolidated statement of operations for the year ended March 31, 2018 and for the purposes of the unaudited pro forma condensed interim consolidated statement of operations for the three months ended June 30, 2018.
The accounting policies used in the preparation of the unaudited pro forma condensed consolidated financial statements are consistent with those described in the consolidated financial statements of Canopy for the year ended March 31, 2018 except for the accounting policy with respect to production and fulfillment related depreciation which was changed as of April 1, 2018, and the adoption of IFRS 9 and 15 on April 1, 2018. These changes were described in note 3 to the condensed interim consolidated financial statement for the three months ended June 30, 2018. There was no change to the comparative periods or transitional adjustments arising from the adoption of IFRS 9 and 15 on April 1, 2018.
The unaudited pro forma condensed consolidated financial statements are not necessarily indicative of the results of operations that would have occurred had the acquisition of the Partner's interest in BC Tweed been effected on the dates indicated, nor are the unaudited pro forma condensed consolidated financial statements indicative of the results of operation of future periods. Actual amounts recorded upon consummation of the proposed acquisition will differ from such unaudited pro forma condensed consolidated financial statements. Since the pro forma condensed consolidated financial statements have been developed to retroactively show the effect of a transaction that is expected to occur at a later date (even though this was accomplished by following generally accepted practice and using reasonable assumptions), there are limitations inherent in the very nature of such pro forma data.
2. DESCRIPTION OF TRANSACTION
On July 5, 2018 Canopy acquired the Partner's 33% interest in BC Tweed Joint Venture Inc. ("BC Tweed") (the "Transaction").
Prior to the second quarter of 2019, the Company accounted for its 67% interest in BC Tweed as a joint operation, based on the conclusion that BC Tweed was subject to joint control. During the second quarter of 2019, the Company revised this conclusion and concluded that based on the shareholders' agreements and the contractual terms of the offtake agreement, the significant relevant activities of BC Tweed are unilaterally controlled by the Company. Since the Company had previously recognized the assets, liabilities, revenues and expenses of BC Tweed based on its proportionate share of BC Tweed's output, being 100%, the conclusion that BC Tweed should have been a consolidated subsidiary had no significant impact on the Company's previously issued interim or annual financial statements.
Under the terms of the original BC Tweed Shareholders' Agreement, the Partner had the option to sell its interest in BC Tweed, in whole or in part, to the Company. This resulted in a liability (the "BC Tweed Put Liability") being recorded in Canopy's financial statements at the present value of the expected redemption amount, with changes recorded in net income in the period in which they arose.
As part of the original BC Tweed Shareholders' agreement, BC Tweed had entered into a call option agreement with the Partner to acquire all the limited partnership units of the limited partnerships which hold the greenhouses and related property that BC Tweed is currently leasing for consideration of $73,000.
In consideration for acquiring the Partner's interest, the Company paid $1 million in cash and 13,293,969 shares of the Company of which 5,091,523 shares were released on closing and the remaining 8,202,446 shares were placed in escrow. The shares placed in escrow will be released over a period of up to three years, with the exact timing of release dependent on the occurrence of specified events.
On closing of the Transaction, the call option held by BC Tweed on the limited partnership units of the limited partnerships which hold the greenhouses and related property was amended to effectively increase the call option price by $27,000. This adjustment to the purchase price represents contingent consideration, which has a fair value on the acquisition date of $27,000.
In conjunction with the acquisition of the Partner's interest the Company received an option to acquire the limited partnership units of another limited partnership currently owned by the Partner that holds greenhouse infrastructure in California. The option is exercisable for a purchase price that is the greater of USD $92,000 and the maximum of $190,000 plus the undepreciated book value of the net assets of the partnership on the closing date. The option is exercisable 90 days after the date of US Federal legalization of the growth, cultivation, production and sale of cannabis for medical purposes. The option expires on the earlier of 90 days after the date of US Federal legalization of the growth, cultivation, production and sale of cannabis for medical purposes and July 5, 2023. The option is a derivative instrument that will be measured initially and subsequently at fair value. Given that the growth, cultivation, production and sale of cannabis is not currently federally legal in the US and there can be no assurance that it will be legal, Management has estimated that this instrument has a nominal value at inception.
On closing of the Transaction, Canopy amended the terms of a share-based compensation arrangement with the Partner to accelerate the vesting of 155,158 shares previously issued to the Partner, and to cancel the remaining tranches of the compensation arrangement. As a result, the unamortized balance of the grant date fair value of the shared-based compensation of $954 was expensed immediately.
3. PRO FORMA CONDENSED CONSOLIDATED FINANCIAL POSITION ASSUMPTIONS AND ADJUSTMENTS
The unaudited pro forma condensed interim consolidated statement of financial position of Canopy as at June 30, 2018 has been adjusted to reflect the following transactions as if the acquisition of the Partner's interest in BC Tweed had been completed on June 30, 2018:
The Transaction has been accounted for as the acquisition of a non-controlling shareholder's interest. The consideration paid for the Partner's interest was estimated to be $495,386. The consideration was comprised of:
The total consideration paid to acquire the Partner's 33% interest has been recorded as a charge to Equity of $422,786, which represents the excess consideration paid over the fair value of the put liability of the transaction date of $72,600.
4. PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS AND ADJUSTMENTS
The unaudited pro forma condensed interim consolidated statements of operations of Canopy for the three months ended June 30, 2018 and the unaudited pro forma condensed consolidated statements of operations of Canopy year ended March 31, 2018 have been adjusted to reflect the following transactions as if the acquisition of BC Tweed had been completed on April 1, 2017:
5. PRO FORMA NET INCOME (LOSS) PER SHARE
The pro forma net income (loss) per share for the three months ended June 30, 2018 and the year ended March 31, 2018 is as follows:
| FOR THE THREE MONTHS ENDED JUNE 30, 2018 | ||||
| Pro forma net loss attributable to CGC | (63,977 | ) | ||
| Weighted average shares outstanding | 200,160,740 | |||
| Pro forma shares issued for acquisition | 13,293,969 | |||
| Pro forma weighted average shares outstanding | 213,454,709 | |||
| Pro forma net loss per share | (0.30 | ) |
| FOR THE YEAR ENDED MARCH 31, 2018 | ||||
| Pro forma net loss attributable to CGC | (46,412 | ) | ||
| Weighted average shares outstanding | 177,301,767 | |||
| Pro forma shares issued for acquisition | 13,293,969 | |||
| Pro forma weighted average shares outstanding, basic | 190,595,736 | |||
| Pro forma net loss per share | (0.24 | ) |